Unadjusted and Adjusted Hazard Ratios for mRNA-1273 With BNT162b2 and Ad26.COV2.S (Primary Series) and With BNT162b2 (Booster Dose)
. | Primary Series . | Booster . | ||||
---|---|---|---|---|---|---|
. | mRNA-1273 vs BNT162b2 . | mRNA-1273 vs Ad26.COV2.S . | mRNA-1273 vs BNT162b2 . | |||
Outcome Type . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . |
Any medically attended COVID-19a | 0.76 (0.75–0.78) | 0.77 (0.75–0.78) | 0.50 (0.49–0.52) | 0.50 (0.49–0.52) | 0.81 (0.78–0.85) | 0.86 (0.82–0.90) |
Outpatient COVID-19b | 0.76 (0.74–0.78) | 0.77 (0.75–0.78) | 0.50 (0.48–0.52) | 0.50 (0.48–0.52) | 0.83 (0.79–0.87) | 0.87 (0.83–0.92) |
COVID-19 Hospitalizationc | 0.84 (0.79–0.90) | 0.81 (0.76–0.86) | 0.43 (0.39–0.47) | 0.43 (0.39–0.47) | 0.77 (0.63–0.94) | 0.81 (0.66–0.99) |
. | Primary Series . | Booster . | ||||
---|---|---|---|---|---|---|
. | mRNA-1273 vs BNT162b2 . | mRNA-1273 vs Ad26.COV2.S . | mRNA-1273 vs BNT162b2 . | |||
Outcome Type . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . |
Any medically attended COVID-19a | 0.76 (0.75–0.78) | 0.77 (0.75–0.78) | 0.50 (0.49–0.52) | 0.50 (0.49–0.52) | 0.81 (0.78–0.85) | 0.86 (0.82–0.90) |
Outpatient COVID-19b | 0.76 (0.74–0.78) | 0.77 (0.75–0.78) | 0.50 (0.48–0.52) | 0.50 (0.48–0.52) | 0.83 (0.79–0.87) | 0.87 (0.83–0.92) |
COVID-19 Hospitalizationc | 0.84 (0.79–0.90) | 0.81 (0.76–0.86) | 0.43 (0.39–0.47) | 0.43 (0.39–0.47) | 0.77 (0.63–0.94) | 0.81 (0.66–0.99) |
Details of the codes used to identify COVID-19-related medical encounters are provided in Supplementary Table 2.
Abbreviations: COVID-19, coronavirus disease 2019; EHR, electronic health record; HR, hazard ratio.
Defined as any medical encounter with a COVID-19 diagnosis or positive COVID-19 laboratory test.
Defined as a hospitalization where COVID-19 was listed in any diagnosis position.
Defined as an encounter recorded either in the EHR or on a claim that is not a hospitalization claim.
Unadjusted and Adjusted Hazard Ratios for mRNA-1273 With BNT162b2 and Ad26.COV2.S (Primary Series) and With BNT162b2 (Booster Dose)
. | Primary Series . | Booster . | ||||
---|---|---|---|---|---|---|
. | mRNA-1273 vs BNT162b2 . | mRNA-1273 vs Ad26.COV2.S . | mRNA-1273 vs BNT162b2 . | |||
Outcome Type . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . |
Any medically attended COVID-19a | 0.76 (0.75–0.78) | 0.77 (0.75–0.78) | 0.50 (0.49–0.52) | 0.50 (0.49–0.52) | 0.81 (0.78–0.85) | 0.86 (0.82–0.90) |
Outpatient COVID-19b | 0.76 (0.74–0.78) | 0.77 (0.75–0.78) | 0.50 (0.48–0.52) | 0.50 (0.48–0.52) | 0.83 (0.79–0.87) | 0.87 (0.83–0.92) |
COVID-19 Hospitalizationc | 0.84 (0.79–0.90) | 0.81 (0.76–0.86) | 0.43 (0.39–0.47) | 0.43 (0.39–0.47) | 0.77 (0.63–0.94) | 0.81 (0.66–0.99) |
. | Primary Series . | Booster . | ||||
---|---|---|---|---|---|---|
. | mRNA-1273 vs BNT162b2 . | mRNA-1273 vs Ad26.COV2.S . | mRNA-1273 vs BNT162b2 . | |||
Outcome Type . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . | Unadjusted HR . | Adjusted HR . |
Any medically attended COVID-19a | 0.76 (0.75–0.78) | 0.77 (0.75–0.78) | 0.50 (0.49–0.52) | 0.50 (0.49–0.52) | 0.81 (0.78–0.85) | 0.86 (0.82–0.90) |
Outpatient COVID-19b | 0.76 (0.74–0.78) | 0.77 (0.75–0.78) | 0.50 (0.48–0.52) | 0.50 (0.48–0.52) | 0.83 (0.79–0.87) | 0.87 (0.83–0.92) |
COVID-19 Hospitalizationc | 0.84 (0.79–0.90) | 0.81 (0.76–0.86) | 0.43 (0.39–0.47) | 0.43 (0.39–0.47) | 0.77 (0.63–0.94) | 0.81 (0.66–0.99) |
Details of the codes used to identify COVID-19-related medical encounters are provided in Supplementary Table 2.
Abbreviations: COVID-19, coronavirus disease 2019; EHR, electronic health record; HR, hazard ratio.
Defined as any medical encounter with a COVID-19 diagnosis or positive COVID-19 laboratory test.
Defined as a hospitalization where COVID-19 was listed in any diagnosis position.
Defined as an encounter recorded either in the EHR or on a claim that is not a hospitalization claim.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.